KRAS MUTATION IN EGFR WILD TYPE INDONESIAN LUNG CANCER PATIENT

被引：0
|
作者：
Masykura, Najmiatul [1 ]
Kharunisa, Bela Haifa [1 ]
Zaini, Jamal [2 ,3 ]
Andarini, Sita Laksmi [2 ,3 ]
Hudoyo, Achmad [2 ,3 ]
Syahruddin, Elisna [2 ]
Hidajat, Heriawaty [2 ]
Widjajahakim, Grace [4 ]
Utomo, Ahmad [1 ,4 ]
机构：
[1] Kalbe Farma Tbk, Stem Cell & Canc Inst, Kota Jakarta Timur, Indonesia
[2] Persahabatan Hosp, Jakarta, Indonesia
[3] Univ Indonesia, Fac Med, Jakarta, Indonesia
[4] Kalbe Genom Lab, Jakarta Timur, Indonesia
来源：
RESPIROLOGY | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO159
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [41] EGFR inhibition is effective against KRAS-wild-type disease
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (09) : 525 - 525
  • [42] Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS
    Gil Pinheiro
    Tania Pereira
    Catarina Dias
    Cláudia Freitas
    Venceslau Hespanhol
    José Luis Costa
    António Cunha
    Hélder P. Oliveira
    Scientific Reports, 10
  • [43] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
    Wang, J. -Y.
    Lin, S. -R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
  • [44] Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS
    Pinheiro, Gil
    Pereira, Tania
    Dias, Catarina
    Freitas, Claudia
    Hespanhol, Venceslau
    Costa, Jose Luis
    Cunha, Antonio
    Oliveira, Helder P.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] EFGR expression in patients with wild type KRAS mutation status: Avoiding unnecessary exposure to anti-EGFR therapies
    Jaballah, A.
    Guettiti, H. Tounsi
    Ben Ayed, I.
    Yaiche, H.
    Habbachi, E.
    Maaloul, A.
    Kabbage, M.
    Mezghanni, N.
    Abdellialc, S.
    Boubaker, S.
    VIRCHOWS ARCHIV, 2016, 469 : S168 - S168
  • [46] Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
    Tseng, Jeng-Sen
    Wang, Chih-Liang
    Huang, Ming-Shyan
    Chen, Chung-Yu
    Chang, Cheng-Yu
    Yang, Tsung-Ying
    Tsai, Chi-Ren
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Tsai, Meen-Hsin
    Yu, Sung-Liang
    Su, Kang-Yi
    Wu, Chih-Wei
    Yang, Cheng-Ta
    Chen, Yuh-Min
    Chang, Gee-Chen
    PLOS ONE, 2014, 9 (09):
  • [47] Association of systemic inflammation with survival in EGFR wild-type lung cancer
    Chen, X.
    Zhang, L.
    Liu, X.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] Biomarkers of resistance to anti-EGFR in wild type KRAS/BRAF colorectal cancer cell lines
    Kumar, S. Sree
    Price, T.
    Hardingham, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S493 - S493
  • [49] Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
    Chen, Yu
    Shi, Yi
    Lin, Jing
    Ye, Yun-bin
    Wang, Xiao-jie
    Chen, Gang
    Guo, Zeng-qing
    MEDICINE, 2015, 94 (40)
  • [50] KRAS Wild-Type Lung Cancer: A Moving Target in an Era of Genotype Migration
    Oxnard, Geoffrey R.
    Jaenne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) : 3322 - 3324
12345